CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 60 enrolled
Drug / intervention
Obtaining CGF from patientsother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06700161
NCT06700161N/ACompleted
CompareCT.gov

Investigation of Lipoxin A4, Annexin A1 and Interleukin-1 Beta Levels in Gingival Crevicular Fluid in Individuals With Stage 3 Grade A Periodontitis

Eda Cetin Ozdemir·observational·Posted Nov 21, 2024·Updated Nov 21, 2024

In Brief

An observational study evaluating Obtaining CGF from patients for Peridontal Disease. Completed, enrolled 60 participants across 1 site.

Detailed Summary

Since the researchers thought that Annexin A1, Lipoxin A4 and IL-1 Beta parameters, which have been found to be related to inflammatory conditions, may increase in periodontitis, a common inflammatory gum disease, we wanted to evaluate the changes in Annexin A1, Lipoxin A4 and IL-1 Beta levels in the Gingival Crevicular Fluid of participants with periodontitis.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPeridontal Disease
CountriesTurkey (Türkiye)
Collaborators--

Timeline

N/ACompletedFinished
20252026
First PostedNov 21, 2024
Enrollment StartMar 16, 2024
Primary CompletionOct 31, 2024
Study CompletionNov 1, 2024
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 1.6 years ago

Interventions

Obtaining CGF from patientsother

Periodontal clinical parameters and Annexin and Lipoxin parameters in CGF will be compared between the test and control groups